Show simple item record

dc.contributor.authorIrungu, Beatrice N
dc.contributor.authorAdipoa, Nicholas
dc.contributor.authorOrwa, Jennifer A.
dc.contributor.authorKimanic, Francis
dc.contributor.authorHeydenreich, Matthias
dc.contributor.authorMidiwoe, Jacob O
dc.contributor.authorBjöremark, Per Martin
dc.contributor.authorHåkanssonb, Mikael
dc.contributor.authorYenesew, Abiy
dc.contributor.authorErdélyi, Máté
dc.date.accessioned2015-09-24T07:48:44Z
dc.date.available2015-09-24T07:48:44Z
dc.date.issued2015-08
dc.identifier.citationIrungu, B. N., Adipo, N., Orwa, J. A., Kimani, F., Heydenreich, M., Midiwo, J. O., ... & Erdélyi, M. (2015). Antiplasmodial And Cytotoxic Activities Of The Constituents Of Turraea Robusta And Turraea Nilotica. Journal of ethnopharmacology.en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S0378874115301070
dc.identifier.urihttp://hdl.handle.net/11295/91420
dc.description.abstractEthnopharmacological relevance Turraea robusta and Turraea nilotica are African medicinal plants used for the treatment of a wide variety of diseases, including malaria. The genus Turraea is rich in limonoids and other triterpenoids known to possess various biological activities. Materials and methods From the stem bark of Turraea robusta six compounds, and from various parts of Turraea nilotica eleven compounds were isolated by the use of a combination of chromatographic techniques. The structures of the isolated compounds were elucidated using NMR and MS, whilst the relative configuration of one of the isolated compounds, toonapubesin F, was established by X-ray crystallography. The antiplasmodial activities of the crude extracts and the isolated constituents against the D6 and W2 strains of Plasmodium falciparum were determined using the semiautomated micro dilution technique that measures the ability of the extracts to inhibit the incorporation of (G-3H, where G is guanine) hypoxanthine into the malaria parasite. The cytotoxicity of the crude extracts and their isolated constituents was evaluated against the mammalian cell lines African monkey kidney (vero), mouse breast cancer (4T1) and human larynx carcinoma (HEp2). Results The extracts showed good to moderate antiplasmodial activities, where the extract of the stem bark of T. robusta was also cytotoxic against the 4T1 and the HEp2 cells (IC50<10 μg/ml). The compounds isolated from these extracts were characterized as limonoids, protolimonoids and phytosterol glucosides. These compounds showed good to moderate activities with the most active one being azadironolide, IC50 2.4±0.03 μM and 1.1±0.01 μM against the D6 and W2 strains of Plasmodium falciparum, respectively; all other compounds possessed IC50 14.4-40.5 μM. None of the compounds showed significant cytotoxicity against vero cells, yet four of them were toxic against the 4T1 and HEp2 cancer cell lines with piscidinol A having IC50 8.0±0.03 and 8.4 ±0.01 μM against the 4T1 and HEp2 cells, respectively. Diacetylation of piscidinol A resulted in reduced cytotoxicity. Conclusion From the medicinal plants Turraea robusta and Turraea nilotica, twelve compounds were isolated and characterized; two of the isolated compounds, namely 11-epi-toonacilin and azadironolide showed good antiplasmodial activity with the highest selectivity indices.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.subjectTurraea robusta; Turraea nilotica; Antiplasmodial activity; Cytotoxicity; Limonoid; Toonapubesins F; Toonacilin; Azadironolideen_US
dc.titleAntiplasmodial and cytotoxic activities of the constituents of turraea robusta and turraea niloticaen_US
dc.type.materialen_USen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record